Fecal transplant study for cancer treatment side effects
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether fecal transplants (putting healthy donor bacteria into your gut) can help with side effects like diarrhea, constipation, or nausea caused by cancer treatments. It is for people with advanced gastrointestinal cancer who are about to start their fourth round of chemo or targeted therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been diagnosed with advanced (stage 4) gastrointestinal cancer, such as stomach, colon, or rectal cancer.
- You have had at least 3 cycles of chemotherapy or targeted therapy and have experienced stomach-related side effects like diarrhea, constipation, or nausea.
- You are planning to receive your 4th cycle of chemo or targeted therapy.
- You have had a PD-1 or PD-L1 test (a test that checks for certain proteins on your cancer cells).
- You are able to swallow capsules without chewing and can give informed consent.
- You are not currently taking broad-spectrum antibiotics (unless approved by the doctor) and do not have a serious infection or organ failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting healthy gut bacteria (called a fecal microbiota transplant, or FMT) can help people with advanced cancer who are losing weight and muscle. The goal is to see if it improves appetite and helps you maintain strength.
This study tests whether giving patients healthy donor stool bacteria (fecal microbiota transplantation) can reduce or prevent nausea, diarrhea, and other stomach or bowel problems caused by cancer treatment. It is for people with extrapulmonary neuroendocrine tumors who have had gastrointestinal side effects during their first three treatment cycles.
This trial tests a treatment called “washed microbiota transplant,” which transfers healthy gut bacteria to help relieve intestinal problems that started after cancer therapy. You might benefit if you’re an adult with certain ongoing stomach or bowel symptoms after standard cancer treatment, and your body is stable enough for the procedure.
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
This trial tests whether a treatment called fecal microbiota transplant (FMT) — transferring healthy gut bacteria — can help relieve diarrhea and colitis caused by immunotherapy drugs. If you have melanoma or kidney cancer and are experiencing diarrhea after immunotherapy, this study may offer a new option.
This trial tests whether transplanting healthy donor bacteria (fecal microbiota) into the gut can help adults with blood cancers who have stubborn infections, C. diff, or complications after stem cell transplant. It may reduce dangerous germs and improve gut health.
Hear when a new Antineoplastic Agents trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.